Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunome Q1 EPS $(0.52) Beats $(0.68) Estimate, Sales $2.93M Beat $285.71K Estimate

Author: Benzinga Newsdesk | May 12, 2025 03:26pm
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.68) by 23.53 percent. This is a 79.28 percent increase over losses of $(2.51) per share from the same period last year. The company reported quarterly sales of $2.93 million which beat the analyst consensus estimate of $285.71 thousand by 924.10 percent. This is a 184.35 percent increase over sales of $1.03 million the same period last year.

Posted In: IMNM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist